Hugh Murray
Hugh is the Upstream Process Development Manager at MilliporeSigma's Viral Vector CDMO in Carlsbad, CA, with over a decade of experience designing and scaling mammalian suspension processes for biologics and gene therapy. He specializes in DoE methodology, predictive modeling, automated micro-bioreactor and liquid handling platforms, and scaling bench-scale processes to large-scale single-use bioreactors - leading the development of workflows that can take a clients 'gene and a dream' into clinical phase manufacturing rapidly and efficiently. Prior to the viral vector space, Hugh worked in mAb process development, characterization, and validation at Tanvex BioPharma Inc., including authoring BLA CMC sections for biosimilar approval and managing MSAT teams during phase III clinical material production.